Posts Tagged ‘high blood pressure’

RSS

October 27th, 2014

Selections from Richard Lehman’s Literature Review: October 27th

This week’s topics include behavioral counseling for those with CV risk factors, long-term outcomes after stenting vs. endarterectomy for treatment of symptomatic carotid stenosis, and more.


February 25th, 2011

FDA Approves Azilsartan Medoxomil (Edarbi) for High Blood Pressure

The FDA has approved azilsartan medoxomil (Edarbi, Takeda) for the treatment of high blood pressure. The new angiotensin II receptor blocker (ARB) will be available in 80 mg and 40 mg doses. The recommended dose is 80 mg once daily. The 40 mg dose is used in combination with a diuretic. The FDA said that, in clinical studies, […]